More Patients For Amedisys
Leading US player in the home health and hospice segment, Amedisys (NASDAQ:AMED) has inked a deal to acquire Beacon Hospice, a Boston-based company for $125 million. The deal is subject to customary closing conditions, including regulatory approvals. Apart from expanding Amedysis’ presence in the New England region, the proposed acquisition of Beacon is expected to [...]
Leading US player in the home health and hospice segment, Amedisys (NASDAQ:AMED) has inked a deal to acquire Beacon Hospice, a Boston-based company for $125 million. The deal is subject to customary closing conditions, including regulatory approvals.
Apart from expanding Amedysis’ presence in the New England region, the proposed acquisition of Beacon is expected to add 5−7 cents (excluding one-time expenses) to its fiscal 2011 earnings.
As a paramount hospice company of New England, Beacon … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards